Description
CJC-1295 with DAC Research Material — 5mg
Material identity: CJC-1295 with DAC. Declared quantity: 5mg.
Supplied exclusively for legitimate laboratory, analytical, and in-vitro research, including analytical characterization, reference comparison, method development, and controlled non-clinical investigation.
Documentation and laboratory responsibility
- Review the applicable lot information and Certificate of Analysis before laboratory work.
- Use only in an appropriately equipped laboratory under qualified supervision and applicable institutional procedures.
- The purchaser is responsible for lawful acquisition, storage, handling, recordkeeping, and disposal.
Research Use Only (RUO). For legitimate laboratory, analytical, and in-vitro research only.
NOT FOR HUMAN OR VETERINARY USE, CONSUMPTION, INGESTION, INJECTION, IMPLANTATION, OR OTHER BODILY ADMINISTRATION.
This material is not a drug, food, dietary supplement, cosmetic, or medical product. HealthLab Peptides does not provide dosing, administration, reconstitution, injection, treatment, cycling, or personal-use instructions. It is not intended to diagnose, treat, cure, or prevent disease.
Analytical and in-vitro research context
CJC-1295 with DAC Research Material — 5mg is cataloged exclusively as research-use-only material for legitimate laboratory, analytical, and in-vitro investigation. Relevant scientific terminology for this material includes peptide identity, HPLC and LC-MS characterization, GHRH- or GHS-R1a-related in-vitro assays, cAMP or calcium signaling, receptor expression, kinetics, and desensitization controls. These terms describe possible laboratory measurements and experimental controls; they do not imply a medical, diagnostic, therapeutic, human-use, or veterinary-use purpose.
Before beginning research, laboratories should review the lot-specific Certificate of Analysis and distinguish molecular identity, chromatographic peak-area purity, total material quantity, moisture or counterion contribution, analytical recovery, and functional assay performance. HPLC or UPLC can evaluate retention and resolved peak area, while LC-MS or high-resolution mass spectrometry may support molecular-mass confirmation. When close variants or modification sites matter, tandem mass spectrometry or peptide mapping may provide additional sequence-position evidence.
Useful internal research resources include CJC-1295 without DAC 5mg + IPA 5mg — Research Blend and CJC-1295 without DAC + IPA — 10mg Research Blend. Researchers may also read this related HealthLab laboratory article and review the complete HealthLab Peptides RUO catalog. Related products are linked for analytical comparison and catalog navigation only; shared terminology does not establish chemical, functional, or lot-to-lot equivalence.







HGH Fragment 176-191 — Research Material
Epitalon Research Material — 50mg
GHRP-2 Research Material — 5mg
CJC-1295 without DAC 5mg + IPA 5mg — Research Blend
AICAR Research Material — 50mg
Sema Research Material — 5mg
Reta Research Material — 40mg
AOD-9604 Research Material — 5mg
MOTS-C Research Material — 10mg
BPC-157 + TB-500 — 10mg Research Blend
GHK-Cu Research Material — 50mg
Ipamorelin Research Material — 10mg
SLU-PP-332 Research Material — 5mg
MT-1 Research Material — 10mg